Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instituto Plantando Consciência is a Brazilian non-profit research organization dedicated to the scientific study of psychedelic substances and their therapeutic potential. The institute focuses on bridging the gap between traditional indigenous knowledge and modern clinical science, particularly regarding substances like ayahuasca and psilocybin. Their work encompasses pharmacological research, clinical trial design, and advocacy for the decriminalization and medical regulation of psychedelics in Brazil. By collaborating with leading academic institutions, the institute aims to develop new mental health treatments for conditions such as treatment-resistant depression and PTSD. They also provide educational resources and training for healthcare professionals interested in psychedelic-assisted therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instituto Plantando Consciência.